论文部分内容阅读
广州迈普再生医学科技有限公司(以下简称“迈普”或“公司”)成立于2008年9月2日,主营业务为:再生型植入式医疗器械产品的研发、生产与销售。由于医疗器械行业具有研发周期长、前期投入大、风险高等特点,目前公司仍处于创业阶段,且成立至今已投入了大量资金进行技术平台和产业化基地建设,尚未实现大规模经济效益。但产值等逐年上升,且增速迅猛。作为生物3D打印和再生医学领域的前行者,迈普已成功实现人工硬脑(脊)膜、无张力尿失禁悬
Founded in September 2, 2008, Guangzhou Maipu Regenerative Medicine Technology Co., Ltd. (hereinafter referred to as “Maipu” or “Company”) is principally engaged in the R & D and production of regenerative implantable medical devices With sales. Due to its long R & D cycle, high initial investment and high risk, the medical device industry is still in its infancy. Since its establishment, it has invested a large amount of funds in the construction of its technology platform and industrialization base and has not yet achieved large-scale economic benefits. However, the output value has risen year by year and has been growing rapidly. As a pioneer in the field of biological 3D printing and regenerative medicine, Maipu has successfully achieved artificial dural (spinal) membrane, tension-free urinary incontinence suspension